Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1/2 5Phase 3 4Phase 2/3 2Phase 1 2

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Sarcoma 1Head & Neck 1

Conditions

Colorectal Neoplasms 71Rectal Neoplasms 38Pancreatic Neoplasms 32Colonic Neoplasms 31Neoplasms 29Stomach Neoplasms 22Neoplasm Metastasis 22Carcinoma, Non-Small-Cell Lung 18Esophageal Neoplasms 16Unspecified Adult Solid Tumor, Protocol Specific 15Head and Neck Neoplasms 13Adenocarcinoma 11Squamous Cell Carcinoma of Head and Neck 10Breast Neoplasms 10Ovarian Neoplasms 8Lung Neoplasms 8Lymphoma, Non-Hodgkin 6Esophageal Squamous Cell Carcinoma 6Carcinoma, Renal Cell 6Solid Tumor 5Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Gallbladder Neoplasms 5Cholangiocarcinoma 5Adenocarcinoma Of Esophagus 5Triple Negative Breast Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Peritoneal Neoplasms 4Melanoma 4Liver Neoplasms 4

Interventions

Gemcitabine 13Cisplatin 9Capecitabine 7durvalumab 6pembrolizumab 4tremelimumab 3S 1 (combination) 3Nivolumab 3AZD 6244 3Ramucirumab 2Fluorouracil 2130-nm albumin-bound paclitaxel 2vandetanib 1trifluridine tipiracil drug combination 1trametinib 1tocilizumab 1titanium silicide 1sacituzumab govitecan 1poly ICLC 1futibatinib 1fludarabine 1cemiplimab 1binimetinib 1aflibercept 1Tegafur 1TAS-116 1Psilocybin 1Peptides 1Oxaliplatin 1NUC-1031 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Biliary Tract Neoplasms × Fluorouracil × Clear all
NCT04999761 2024-09-25

AB122 Platform Study

Taiho Pharmaceutical Co., Ltd.

Phase 1 Recruiting
917 enrolled
GastrointestinalHead & NeckSarcomaThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Sarcoma, Alveolar Soft Part

NCT04480190 2022-04-20

Neoadjuvant Therapy in Biliary Adenocarcinoma

University of Cincinnati

Phase 1 Withdrawn
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡